|

intraportal islet autotransplantation Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • University Hospital, Lille1

Indications

  • Ampullary Adenocarcinoma1
  • Adenocarcinoma of the Duodenum1
  • Adenocarcinoma of the Pancreas1
  • Cancer1

Other1 trial

Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.